Company News in the Life Science Industry

»

Reset 

ForaCare Suisse AG Launches "Lab in the Pocket" Technology

Innovative FORA 6 GTel Capability Provides 6 Tests with Single Device, SIM Direct-to-Telehealth Connectivity

Read more ››
By: PR Newswire Association LLC. - 04 Dec 2019

Dong-A ST and Beactica Therapeutics Achieve Key Milestone in Their Collaboration to Develop New Cancer Treatments

STOCKHOLM, Dec. 4, 2019 /PRNewswire/ -- Dong-A ST Co., Ltd. (170900: Korea SE), a Korean pharmaceutical company, and Beactica Therapeutics AB, a Swedish drug discovery company, today announced that a lead compound meeting certain pre-defined criteria has been selected in their collaborative research... Read more ››

By: PR Newswire Association LLC. - 04 Dec 2019

Bionorica selects Movilitas Services and Solutions for Compliance with the Russian Serialization Law

COLUMBIA, Md., Dec. 4, 2019 /PRNewswire/ -- Movilitas, a technology leader delivering the next generation of solutions and consulting services across multiple industries to advance smart supply chain ecosystems, announced today that Bionorica, one of the leading global manufacturers of herbal... Read more ››

By: PR Newswire Association LLC. - 04 Dec 2019

Visiongain Report Provides Critical Market-led Data on the 57bn Biomarkers Market

- Global Biomarkers Market Forecast to 2029

Read more ››
By: PR Newswire Association LLC. - 04 Dec 2019

Brachytherapy Proves Effective in Treating Skin Cancer

CHICAGO, Dec. 4, 2019 /PRNewswire/ -- The use of high-dose-rate brachytherapy to treat elderly patients with common skin cancers offers excellent cure rates and cosmetic outcomes, according to a new study presented today at the annual meeting of the Radiological Society of North America (RSNA).

... Read more ››
By: PR Newswire Association LLC. - 04 Dec 2019

Study Finds Key Brain Region Smaller in Birth Control Pill Users

CHICAGO, Dec. 4, 2019 /PRNewswire/ -- Researchers studying the brain found that women taking oral contraceptives, commonly known as birth control pills, had significantly smaller hypothalamus volume, compared to women not taking the pill, according to a new study presented today at the annual... Read more ››

By: PR Newswire Association LLC. - 04 Dec 2019

Global Cytogenetics Technologies, Companies & Markets, 2018-2023 & 2028

DUBLIN, Dec. 4, 2019 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 04 Dec 2019

Care Dimensions Improves Quality of Life for Hospice Patients Using Telehealth

DANVERS, Mass., Dec. 4, 2019 /PRNewswire/ -- Care Dimensions has achieved an average 30-day hospital readmission rate of 1.38% over one year for hospice patients enrolled in the telehealth program. In 2018, Care Dimensions partnered with Health Recovery Solutions (HRS), a nationally recognized... Read more ››

By: PR Newswire Association LLC. - 04 Dec 2019

Okayama University Research - Primary Intraocular Lymphoma Does Not Always Spread to the Central Nervous System

OKAYAMA, Japan, Dec. 4, 2019 /PRNewswire/ -- Researchers at Okayama University report in the Journal of Clinical and Experimental Hematopathology that primary intraocular lymphoma, a cancer in the eye, does not always develop into central nervous system lymphoma. In addition, the scientists... Read more ››

By: PR Newswire Association LLC. - 04 Dec 2019

Global Biomarkers Companies, Technologies, Markets 2018-2028: Proteomics, Metabolomics, Molecular Diagnostics, Drug Discovery, Clinical Trials, and Bioinformatics

DUBLIN, Dec. 4, 2019 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 04 Dec 2019

ImCheck Raises $53 Million Series B to Advance Clinical Pipeline of Novel Gamma Delta T-Cell-Focused Antibodies for Cancer and Autoimmune Diseases

Read more ››
By: GlobenewsWire - 04 Dec 2019

Novadip Biosciences to present data at 17th Annual Meeting of the International Federation for Adipose Therapeutics and Science

Read more ››
By: GlobenewsWire - 04 Dec 2019
Related companies:  Novadip Biosciences

INNATE PHARMA RELEASES ITS FINANCIAL CALENDAR FOR 2020

Read more ››
By: GlobenewsWire - 04 Dec 2019
Related companies:  Innate Pharma S.A.

FDA approves Roche’s Tecentriq plus chemotherapy (Abraxane and carboplatin) for the initial treatment of metastatic non-squamous non-small cell lung cancer

Read more ››
By: GlobenewsWire - 04 Dec 2019
Related companies:  F. Hoffmann-La Roche AG (Venture Fund) | Hoffmann-La Roche Limited (Roche Canada) | F. Hoffmann-La Roche AG | Hoffmann-La Roche Ltd. (Edmonton)

Merck and Ping An Good Doctor Form Strategic Collaboration to Advance Intelligent Healthcare in China

SHANGHAI, Dec. 4, 2019 /PRNewswire/ -- Merck, a leading science and technology company, signed a strategic collaboration agreement today with one of the world's leading healthcare ecosystem platforms, Ping An Healthcare and Technology Company Limited (Stock code: "Ping An Good Doctor", 1833.HK).... Read more ››

By: PR Newswire Association LLC. - 04 Dec 2019

ViewRay Announces Pricing of Public Offering of Common Stock

CLEVELAND, Dec. 4, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY), maker of the MRIdian, which combines MRI and external-beam radiation therapy to simultaneously image and treat cancer patients, today announced the pricing of an underwritten public offering of 41,550,000 shares of common stock... Read more ››

By: PR Newswire Association LLC. - 04 Dec 2019
Related companies:  ELEKTA AB | Medtronic Plc | ViewRay, Inc.

CASI Pharmaceuticals Announces China NMPA Approval Of CNCT19 (CD19 CAR-T) Clinical Trial Applications

ROCKVILLE, Md. and BEIJING, Dec. 3, 2019 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, announces that the China National Medical Product Administration... Read more ››

By: PR Newswire Association LLC. - 04 Dec 2019
Related companies:  CASI Pharmaceuticals, Inc.

Kodiak Sciences Announces Pricing of $276.0 Million Public Offering of Common Stock

PALO ALTO, Calif., Dec. 3, 2019 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a clinical stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, today announced the pricing of an underwritten public offering of 6,000,000 shares... Read more ››

By: PR Newswire Association LLC. - 04 Dec 2019
Related companies:  Kodiak Sciences Inc.

Relmada Therapeutics Announces Pricing of Public Offering of Common Stock

NEW YORK, Dec. 3, 2019 /PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) diseases, today announced the pricing of an offering of 3,333,334 shares of its common stock at a public offering... Read more ››

By: PR Newswire Association LLC. - 04 Dec 2019
Related companies:  Relmada Therapeutics, Inc.

Khiron Welcomes Legalization of Medical Cannabis in Brazil

TORONTO, Dec. 4, 2019 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: Read more ››

By: PR Newswire Association LLC. - 04 Dec 2019
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16 17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies